Access the full text.
Sign up today, get DeepDyve free for 14 days.
Masami Sato, Y. Mori, A. Sakurada, S. Fukushige, Y. Ishikawa, E. Tsuchiya, Yasuki Saito, T. Nukiwa, S. Fujimura, A. Horii (1998)
Identification of a 910‐Kb region of common allelic loss in chromosome bands 16q24.1–q24.2 in human lung cancerGenes, 22
G. Saccomanno, V. Archer, O. Auerbach, R. Saunders, Lola Brennan (1974)
Development of carcinoma of the lung as reflected in exfoliated cellsCancer, 33
(1999)
Histological typing of tumours of lung and pleura
M. Barrett, C. Sanchez, L. Prevo, D. Wong, P. Galipeau, T. Paulson, P. Rabinovitch, B. Reid (1999)
Evolution of neoplastic cell lineages in Barrett oesophagusNature Genetics, 22
A. Pasic, A. Vonk-Noordegraaf, E. Risse, P. Postmus, T. Sutedja (2003)
Multiple suspicious lesions detected by autofluorescence bronchoscopy predict malignant development in the bronchial mucosa in high risk patients.Lung cancer, 41 3
F. Hirsch, W. Franklin, A. Gazdar, P. Bunn (2001)
Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 1
(1999)
World Health Organisation International classification of tumours
I. Wistuba, C. Behrens, S. Milchgrub, D. Bryant, J. Hung, J. Minna, A. Gazdar (1999)
Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinomaOncogene, 18
Masami Sato, Y. Mori, A. Sakurada, S. Fujimura, Akira Horii (1998)
The H-cadherin (CDH13) gene is inactivated in human lung cancerHuman Genetics, 103
(2013)
Comparative Genomic Hybridization: Implications of the
H. Telenius, N. Carter, C. Bebb, Magnus Nordenskjo¨ld, B. Ponder, A. Tunnacliffe (1992)
Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer.Genomics, 13 3
V. Sundaresan, P. Ganly, P. Hasleton, R. Rudd, G. Sinha, N. Bleehen, P. Rabbitts (1992)
p53 and chromosome 3 abnormalities, characteristic of malignant lung tumours, are detectable in preinvasive lesions of the bronchus.Oncogene, 7 10
S. Shahnavaz, G. Bradley, J. Regezi, N. Thakker, L. Gao, D. Hogg, R. Jordan (2001)
Patterns of CDKN2A gene loss in sequential oral epithelial dysplasias and carcinomas.Cancer research, 61 6
J. Boyle, F. Lonardo, J. Chang, D. Klimstra, V. Rusch, E. Dmitrovsky (2001)
Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.Clinical cancer research : an official journal of the American Association for Cancer Research, 7 2
G. Chung, V. Sundaresan, P. Hasleton, R. Rudd, R. Taylor, P. Rabbitts (1996)
Clonal evolution of lung tumors.Cancer research, 56 7
P. Massion, Peter Taflan, S. Rahman, P. Yildiz, Y. Shyr, M. Edgerton, M. Westfall, J. Roberts, J. Pietenpol, D. Carbone, Adriana Gonzalez (2003)
Significance of p63 amplification and overexpression in lung cancer development and prognosis.Cancer research, 63 21
M. Takeichi (1993)
Cadherins in cancer: implications for invasion and metastasis.Current opinion in cell biology, 5 5
Y. Sekido, K. Fong, J. Minna (1988)
Molecular genetics of lung cancer.Annual review of medicine, 54
Y. Satoh, Y. Ishikawa, K. Nakagawa, T. Hirano, E. Tsuchiya (1997)
A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers.British Journal of Cancer, 75
Suzana Bota, J. Auliac, Christophe Paris, Josette Métayer, Richard Sesboüé, Georges Nouvet, Luc Thiberville (2001)
Follow-up of bronchial precancerous lesions and carcinoma in situ using fluorescence endoscopy.American journal of respiratory and critical care medicine, 164 9
Grace Chung, V. Sundaresan, P. Hasleton, R. Rudd, R. Taylor, Pamela Rabbitts (1995)
Sequential molecular genetic changes in lung cancer development.Oncogene, 11 12
N. Shivapurkar, A. Virmani, I. Wistuba, S. Milchgrub, B. Mackay, J. Minna, A. Gazdar (1999)
Deletions of chromosome 4 at multiple sites are frequent in malignant mesothelioma and small cell lung carcinoma.Clinical cancer research : an official journal of the American Association for Cancer Research, 5 1
A. Kallioniemi, O. Kallioniemi, D. Sudar, D. Rutovitz, J. Gray, F. Waldman, D. Pinkel (1992)
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.Science, 258 5083
Wilbur Franklin, Adi Gazdar, Adi Gazdar, J. Haney, I. Wistuba, Francisco Rosa, T. Kennedy, Donald Ritchey, York Miller (1997)
Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis.The Journal of clinical investigation, 100 8
O. Auerbach, Thomas Petrick, A. Stout, A. Statsinger, G. Muehsam, Jerome Forman, J. Gere (1956)
The anatomical approach to the study of smoking and bronchogenic carcinoma. a preliminary report of forty‐one casesCancer, 9
B. Venmans, T. Boxem, E. Smit, P. Postmus, T. Sutedja (2000)
Outcome of bronchial carcinoma in situ.Chest, 117 6
(1997)
Comparative genomic hybridization analysis detects frequent, often high-level, over-representation of DNA sequences at 3q, 5p, 7p, and 8q in human non–small cell lung carcinomas
K. Heselmeyer, E. Schröck, S. Manoir, H. Blegen, K. Shah, R. Steinbeck, G. Auer, T. Ried (1996)
Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix.Proceedings of the National Academy of Sciences of the United States of America, 93 1
Jaclyn Hung, Yosuke Kishimoto, Kenji Sugio, A. Virmani, Donald McIntire, J. Minna, A. Gazdar (1995)
Allele-specific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.JAMA, 273 7
S. Stanton, Sang Shin, B. Johnson, M. Meyerson (2000)
Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomasGenes, 27
A. Banerjee, P. Rabbitts, P. George (2004)
Preinvasive bronchial lesions: surveillance or intervention?Chest, 125 5 Suppl
G. Sozzi, M. Oggionni, L. Alasio, D. Conte, L. Tavecchio, S. Pilotti, P. Spinelli, G. Calarco (2002)
Molecular changes track recurrence and progression of bronchial precancerous lesions.Lung cancer, 37 3
O. Auerbach, Stout Ap, Hammond Ec, L. Garfinkel (1961)
Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer.The New England journal of medicine, 265
H. Usadel, J. Brabender, K. Danenberg, C. Jerónimo, S. Harden, J. Engles, P. Danenberg, Stephen Yang, D. Sidransky (2002)
Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer.Cancer research, 62 2
CINDY Cooper, V. Bubb, Nicola Smithson, ROBERT Carter, S. Gledhill, D. Lamb, A. Wyllie, Francis Carey (1996)
LOSS OF HETEROZYGOSITY AT 5q21 IN NON‐SMALL CELL LUNG CANCER: A FREQUENT EVENT BUT WITHOUT EVIDENCE OF APC MUTATIONThe Journal of Pathology, 180
A. Ponticiello, E. Barra, U. Giani, M. Bocchino, A. Sanduzzi (2000)
P53 immunohistochemistry can identify bronchial dysplastic lesions proceeding to lung cancer: a prospective study.The European respiratory journal, 15 3
L. Thiberville, P. Payne, J. Vielkinds, J. Leriche, D. Horsman, G. Nouvet, B. Palcic, S. Lam (1995)
Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus.Cancer research, 55 22
Bhuvanesh Singh, Archontoula Stoffel, Swarna Gogineni, A. Poluri, D. Pfister, A. Shaha, A. Pathak, G. Bosl, C. Cordon-Cardo, J. Shah, P. Rao (2002)
Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.The American journal of pathology, 161 2
Stephen Lam, C. MacAulay, J. Leriche, B. Palcic (2000)
Detection and localization of early lung cancer by fluorescence bronchoscopyCancer, 89
Carcinomas are believed to develop by incremental steps of increasingly abnormal morphology driven by accumulating somatic genetic changes. This process is often difficult to study, as the early stages are undetectable. We used fluorescence bronchoscopy, which enhances detection of preinvasive bronchial lesions, and have obtained sequential biopsies of carcinoma in situ (CIS) from a patient with no detectable tumor and from a squamous cell carcinoma that developed 19 months after presentation at the site of one of the previous CIS lesions. Biopsies of preinvasive CIS, which follow‐up showed had different pathologic outcomes, and tumor were microdissected to obtain enriched cell populations and DNA prepared from them. Molecular characteristics of these biopsies were compared by loss of heterozygosity analysis, TP53 mutation analysis, and comparative genomic hybridization. Although all lesions examined had the same TP53 mutation and almost identical allelotypes, differences were observed. Loss in 5q21 and amplification of 3q25–26 were associated with the lesion that progressed and the subsequent carcinoma. Allele loss at 4p16 was detected in the tumor but not in any of the CIS lesions, suggesting it was a late event associated with tumor invasion. Amplification at 4q12 was specifically observed in the tumor and in the CIS at the site of eventual tumor formation. Although these findings may be unique to this one patient, the successful demonstration of sequential genetic changes raises the possibility that this approach, unencumbered by interpatient variability between lesions, will greatly facilitate the identification of molecular events driving the invasive process © 2005 Wiley‐Liss, Inc.
Genes, Chromosomes and Cancer – Wiley
Published: Sep 1, 2005
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.